A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms
José I. Martín‐Subero(Institució Catalana de Recerca i Estudis Avançats), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Inga Nagel(Christian-Albrechts-Universität zu Kiel), Jan Dürig(West German Heart and Vascular Center Essen), Sara Álvarez(Centro Nacional de Epidemiología), Juan C. Cigudosa(Centro Nacional de Epidemiología), Lana Harder(Franklin University), Felipe Prósper(Clinica Universidad de Navarra), Manuel Montesinos‐Rongen(University Hospital Cologne), Stefan Gesk(Christian-Albrechts-Universität zu Kiel), Sylvia Hartmann(Goethe University Frankfurt), Ole Ammerpohl(Christian-Albrechts-Universität zu Kiel), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Marina Bibikova(Illumina (United States)), Martina Deckert(University Hospital Cologne), Eliza Wickham‐Garcia(Illumina (United States)), Julia Richter(German Cancer Research Center), Jian‐Bing Fan(Illumina (United States)), Martin Dreyling(LMU Klinikum), Stefanie Bug(Christian-Albrechts-Universität zu Kiel), Xabier Agirre(Universidad de Navarra), Monika Brüggemann(Universitäts Hautklinik Kiel), Martin J.S. Dyer(The University of Texas System), Marc Seifert(University of Duisburg-Essen), Javier Suela(Centro Nacional de Epidemiología), Marı́a José Calasanz(Aristotle University of Thessaloniki), Ralf Küppers(University of Duisburg-Essen), Martin‐Leo Hansmann(Goethe University Frankfurt), Inga Vater(Christian-Albrechts-Universität zu Kiel), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Harald Stein(Charité - Universitätsmedizin Berlin), Lorenz Trümper(University of Göttingen), José Román‐Gómez(Instituto Maimónides de Investigación Biomédica de Córdoba), Christiane Pott(University Hospital Schleswig-Holstein), Ming‐Qing Du(University of Namur)
Cited by 137
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k